Merck cut a drug discovery cycle by 33% and ships compliant marketing 80% faster. Mastercard is rethinking fraud disputes.
An overview of the activities of selected APT groups investigated and analyzed by ESET Research in Q4 2025 and Q1 2026 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results